Kura Oncology

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Kura Oncology and other ETFs, options, and stocks.

About KURA

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias.

CEO

Troy E. Wilson

CEOTroy E. Wilson

Employees

192

Employees192

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2014

Founded2014

Employees

192

Employees192

KURA Key Statistics

Market cap

518.59M

Market cap518.59M

Price-Earnings ratio

-3.18

Price-Earnings ratio-3.18

Dividend yield

—

Dividend yield—

Average volume

1.77M

Average volume1.77M

High today

$6.47

High today$6.47

Low today

$6.14

Low today$6.14

Open price

$6.30

Open price$6.30

Volume

978.54K

Volume978.54K

52 Week high

$23.48

52 Week high$23.48

52 Week low

$5.41

52 Week low$5.41

Analyst ratings

87%

of 15 ratings

Buy

86.7%

Hold

13.3%

Sell